Latest News

06.14.21

EyeGate Pharma Announces First Patient Dosed for PP-001 in a Phase 2 Proof-of-Concept Ocular Surface Inflammation Study

Source: EyeGate Pharmaceuticals

06.11.21

Reed Exhibitions Unveils New Brand Identity

Source: The Vision Council

06.11.21

Randy Jackson, Patient Advocates to Share Stories of Managing Eye Health While Thriving With Diabetes During Live Virtual Event

Source: VSP Global

06.11.21

OcuGen to No Longer Pursue EUA for Covid-19 Vaccine Candidate Covaxin; Will Pursue Full Approval

Source: Ocugen

06.11.21

US to Buy 500 Million Doses of Pfizer, BioNTech COVID-19 Vaccine for Donation to Poorest Nations

Source: FirstWord

06.10.21

Iveric Bio to Host Investor Symposium on Dry AMD

Source: Iveric bio

06.10.21

Oyster Point Pharma Announces Collaboration with Adaptive Phage Therapeutics to Target Ophthalmic Diseases

Source: Oyster Point Pharma

06.09.21

Lighthouse Guild Announces the Naming of The Dorothy Strelsin Behavioral Health Clinic

Source: Lighthouse Guild

06.09.21

Outlook Therapeutics Completes Patient Dosing in Phase 3 NORSE TWO Trial for Wet AMD

Source: Outlook Therapeutics

06.08.21

EyeYon Medical Receives CE Mark for its EndoArt Implant to Treat Chronic Corneal Edema

Source: EyeYon Medical

View more stories